Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|---|---|
MDA-MB-134-VI | INK-128 | 3.1623 | mTORC1/2 | PI3K/mTOR | -0.8853 | 0.52609 |
MDA-MB-361 | Luminespib | 0.31623 | HSP90 | Misc | -0.8812 | 0.73884 |
HCC70 | Ceritinib | 10.0 | ALK | RTK | -0.8808 | 0.51303 |
HCC70 | Dinaciclib | 0.31623 | pan CDK | Cell cycle | -0.8802 | 0.72250 |
MDA-MB-134-VI | ABT-737 | 10.0 | Bcl2/XL | Misc | -0.8735 | 0.56669 |
MDA-MB-361 | Luminespib | 0.1 | HSP90 | Misc | -0.8712 | 0.72786 |
HCC70 | Dinaciclib | 0.031623 | pan CDK | Cell cycle | -0.8675 | 0.69990 |
HCC1428 | Ceritinib | 10.0 | ALK | RTK | -0.8673 | 0.83636 |
HCC1419 | Ceritinib | 10.0 | ALK | RTK | -0.8670 | 0.78048 |
HCC70 | Topotecan | 10.0 | Topo I | Chemotherapy | -0.8614 | 0.69928 |
MDA-MB-157 | Dinaciclib | 0.1 | pan CDK | Cell cycle | -0.8610 | 0.78558 |
MDA-MB-134-VI | Torin2 | 0.31623 | mTOR/ATM/ATR | PI3K/mTOR | -0.8587 | 0.52277 |
MDA-MB-361 | Taselisib | 1.0 | PI3Ka, g, d | PI3K/mTOR | -0.8577 | 0.70554 |
T47D | Ceritinib | 10.0 | ALK | RTK | -0.8550 | 0.88984 |
MDA-MB-361 | Luminespib | 0.031623 | HSP90 | Misc | -0.8543 | 0.71039 |
PDX1328 | Cediranib | 10.0 | VEGFR/cKIT | RTK | -0.8534 | 0.62581 |
MDA-MB-361 | INK-128 | 3.1623 | mTORC1/2 | PI3K/mTOR | -0.8457 | 0.67173 |
MDA-MB-134-VI | Dinaciclib | 1.0 | pan CDK | Cell cycle | -0.8440 | 0.50908 |
MDA-MB-134-VI | Doxorubicin | 0.31623 | Chemo | Chemotherapy | -0.8349 | 0.47478 |
MDA-MB-157 | Topotecan | 10.0 | Topo I | Chemotherapy | -0.8333 | 0.60008 |
MDA-MB-134-VI | INK-128 | 1.0 | mTORC1/2 | PI3K/mTOR | -0.8266 | 0.46397 |
HCC70 | Abemaciclib | 10.0 | CDK4/6 | Cell cycle | -0.8264 | 0.64288 |
HCC70 | Topotecan | 3.1623 | Topo I | Chemotherapy | -0.8255 | 0.70800 |
SK-BR-3 | Ceritinib | 10.0 | ALK | RTK | -0.8254 | 0.74759 |
MDA-MB-134-VI | Buparlisib | 10.0 | pan PI3K | PI3K/mTOR | -0.8251 | 0.46691 |